2,6,9-trihydroxy-11-(1-hydroxy-2-propanyl)-1,5,10-trimethyl-8-oxatetracyclo[7.4.1.1~7,10~.0~2,7~]pentadec-11-ene-13,15-dione

Metabolite details

Identifier

BKRBOORGXGTRIL-UHFFFAOYSA-N

InChI Key

BKRBOORGXGTRIL-UHFFFAOYSA-N

IUPAC name

2,7a,11-trihydroxy-4-(1-hydroxypropan-2-yl)-3,7,10-trimethyl-2,3,7,7a,8,9,10,11-octahydro-6H-2,7:3,11a-dimethano-1-benzoxonine-6,12-dione

Preferred name

2,6,9-trihydroxy-11-(1-hydroxy-2-propanyl)-1,5,10-trimethyl-8-oxatetracyclo[7.4.1.1~7,10~.0~2,7~]pentadec-11-ene-13,15-dione

INN name

—

Synonym

Cinncassiol C

ChEBI

CHEBI:141539

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Transcriptome and Metabolome Analyses Reveal Differences in Terpenoid and Flavonoid Biosynthesis in Cryptomeria fortunei Needles Across Different Seasons
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• RU-_Control_vs_RU+_Switch
• Summer_vs_Winter
• Control_vs_ZYP_High_Dose